Back
Pliant Therapeutics Stock Price Chart
Sponsored
PLRX
Sponsored
FREE REPORT: 2025 Gold Price Outlook
Get Your Copy of "2025 Gold Forecast: A Perfect Storm for Demand" Here.
Sell
37
PLRX
Pliant Therapeutics
Last Price:
$13.49
Seasonality Move:
6.8%
7 Day Trial
ALL ACCESS PASS
$
7
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PLRX is experiencing buying pressure, which is a positive indicator for future bullish movement.
Pliant Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 13.59 | Sell |
20-day SMA: | 14.03 | Sell |
50-day SMA: | 14.05 | Sell |
200-day SMA: | 13.13 | Buy |
8-day EMA: | 13.61 | Sell |
20-day EMA: | 13.8 | Sell |
50-day EMA: | 13.68 | Sell |
200-day EMA: | 13.8 | Sell |
Pliant Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.09 | Sell |
Relative Strength Index (14 RSI): | 46.75 | Sell |
Chaikin Money Flow: | 233657 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (13.1 - 14.54) | Sell |
Bollinger Bands (100): | (12.01 - 14.39) | Buy |
Pliant Therapeutics Technical Analysis
Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | Dec 23 | Dec 24 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | 23 | 24 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Pliant Therapeutics Stock
Is Pliant Therapeutics Stock a Buy?
-
Pliant Therapeutics share price is 13.49 while PLRX 8-day simple moving average is 13.59, which is a Sell signal.
-
The stock price of PLRX is 13.49 while Pliant Therapeutics 20-day SMA is 14.03, which makes it a Sell.
-
Pliant Therapeutics 50-day simple moving average is 14.05 while PLRX share price is 13.49, making it a Sell technically.
-
PLRX stock price is 13.49 and Pliant Therapeutics 200-day simple moving average is 13.13, creating a Buy signal.
PLRX Technical Analysis vs Fundamental Analysis
Sell
37
Pliant Therapeutics (PLRX)
is a Sell
Is Pliant Therapeutics a Buy or a Sell?
-
Pliant Therapeutics stock is rated a SellThe current Pliant Therapeutics [PLRX] share price is $13.49. The Score for PLRX is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
Pliant Therapeutics Stock Info
Market Cap:
820.9M
Price in USD:
13.49
Share Volume:
345.8K
Pliant Therapeutics 52-Week Range
52-Week High:
19.62
52-Week Low:
10.22
Sell
37
Pliant Therapeutics (PLRX)
is a Sell
Pliant Therapeutics Share Price Forecast
-
What is the Pliant Therapeutics stock price today?The Pliant Therapeutics stock price is 13.49 USD today.
-
Will PLRX stock go up or go down?Pliant Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Pliant Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Pliant Therapeutics is overvalued.
Is Pliant Therapeutics Stock a Buy?
-
Pliant Therapeutics share price is 13.49 while PLRX 8-day exponential moving average is 13.61, which is a Sell signal.
-
The stock price of PLRX is 13.49 while Pliant Therapeutics 20-day EMA is 13.80, which makes it a Sell.
-
Pliant Therapeutics 50-day exponential moving average is 13.68 while PLRX share price is 13.49, making it a Sell technically.
-
PLRX stock price is 13.49 and Pliant Therapeutics 200-day simple moving average is 13.80, creating a Sell signal.
Fundamental Analysis of Pliant Therapeutics
Is Pliant Therapeutics a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.74 per share, and a decrease next year of $0.33 per share.
Technical Analysis of Pliant Therapeutics
Should I short Pliant Therapeutics stock?
-
PLRX Moving Average Covergence Divergence (MACD) indicator is -0.09, suggesting Pliant Therapeutics is a Sell
-
Pliant Therapeutics Relative Strength Index (RSI) is 46.75, which suggest Pliant Therapeutics is oversold
-
The Bollinger Bands (25) for Pliant Therapeutics is (13.1 - 14.54), which suggest Pliant Therapeutics is a Buy
-
The Bollinger Bands (100) for Pliant Therapeutics is (12.01 - 14.39), which suggest Pliant Therapeutics is a Buy
* Pliant Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.